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Death of intestinal crypts and of their constituent cells after
treatment by chemotherapeutic drugs
J.V. Moore
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Summary The number and spatial distribution of necrotic cells in the jejunal crypts of mice, has been
measured after treatment by each of 6 cytotoxic drugs. At the LD1o/8day dose of each drug, the majority of
necrotic cells were found below position 9 and numbers per crypt were similar for all drugs (-8). These
findings resemble those for radiation. However, major differences between agents were found in the calculated
numbers of the microcolony-forming units (MFU) that determine overall crypt survival or ablation after high
doses of cytotoxic agent. Numbers of MFU as assayed by radiation were -80 per crypt, but only 2 when
assayed by mechlorethamine hydrochloride, adriamycin and 5-fluorouracil, and 7 using BCNU. No crypts
were destroyed by either cyclophosphamide or actinomycin D, despite the appearance of numerous necrotic
cells in the lower part of the crypt. We conclude that in drug-treated intestine, necrotic cells may arise from a
non-MFU compartment and the incidence and distributions of such cells are likely to be poor indicators of
the response of the MFU.
In experimental therapy, a major problem is to
attempt to relate results obtained by "classical"
histopathological techniques and by autoradio-
graphy, with those obtained by assays of clonogenic
response. The mucosa of the crypts of the murine
small intestine has been studied intensively by the
former methods. According to Cheng & Bjerknes
(1980), 14 pluripotent stem cells lie in the base of
the crypt, between cell positions 1 and 4. The
mitotic cycle of the undifferentiated cells in this
basal region, is longer than that of the 150 or so
daughter cells in a proliferative, amplification
compartment that occupies the next 10 cell
positions up the crypt. The last 4 or 5 cell positions
before the crypt-villus junction, contain non-
dividing, maturing cells (data from various authors,
summarised in Potten, 1980). Perturbations of this
system by cytotoxic insult, have been measured in
terms of altered cellular kinetics and of the degree
and distribution of histologically-defined cell death
in the crypt columns (e.g. Al-Dewachi et al., 1977).
In contrast, the intestinal crypt microcolony assay
(Withers & Elkind, 1970) measures the capacity of
morphologically- and spatially-unidentified cells in
the crypts to divide repeatedly after high doses of
cytotoxic agents, forming multicellular foci of
regeneration ("microcolonies"). Crypts that fail to
regenerate disappear within 2 or 3 days. When
interpreting the results of this assay, it is generally
assumed that a microcolony can arise from one
surviving, clonogenic (microcolony-forming) cell.
As this is currently unproven, the more general
expression "microcolony-forming unit" (MFU) is
adopted here.
The MFU have variously been identified with (a)
the steady-state stem cells of the crypt, (b) a
fraction of, or (c) all of the proliferative cells in the
crypt. These alternatives based on cellular kinetics
or assay by radiation, have been discussed by Yau
& Cairnie (1979) and by Potten & Hendry (1983).
In previous studies with chemotherapeutic drugs,
we have shown that while a number of alkylating
agents were also capable of ablating whole crypts,
the potent drug cyclophosphamide was not (Moore
& Hendry, 1978; Moore, 1979). It was also shown
that the distributions in the crypt of histologically-
dead cells after y-rays (which kill whole crypts) and
the alkaloid vincristine (which does not), were
different. The cell position corresponding to the
median of the distribution of necrotic cells was 5
for y-rays and 9 for vincristine (Moore et al., 1982).
In the light of these and other findings, it has been
suggested that the ability to ablate crypts might be
associated primarily with killing of cells in the
lower zones of the crypt where, a priori, cells with
high division potential might be expected to reside
(Ijiri & Potten, 1983). The present paper examines
this hypothesis, comparing the ability of each of 6
cytotoxic drugs to ablate crypts, with the
distribution of histologically-defined dead cells
within the crypt.
Materials and methods
Mice
Male B6D2F1 (Paterson) mice aged 9-11 weeks,
mean weight 28.5 g (2 s.d. =4g) were used. The
animals were kept under a 12h dark (18.00 to
06.00), 12h light regimen and were given
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"Labsure" mouse pellets (Labsure Ltd., Poole) and
tap water ad libitum.
Drugs
Unless otherwise indicated, all drugs were dissolved
and diluted in sterile, 0.9% saline. Drugs used were:
1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU;
Bristol Laboratories, Syracuse), dissolved in
absolute ethanol and diluted in saline;
Mechlorethamine hydrochloride (HN2; Boots,
Nottingham); Cyclophosphamide (CY; Ward
Blenkinsop; Wembley); Adriamycin (ADR;
Montedison, Barnet); 5-fluorouracil (5-FU; Roche,
Welwyn Garden City); Actinomycin D (ACT D;
Merck Sharp, Rahway). Drug concentrations (mg
of agent kg-1 of individual mouse body wt) were
administered in injection volumes of 0.4 to 0.5ml.
Injections were given i.p., at 09.00 to 10.00h.
Assays
The effect of graded doses of each drug on survival
of whole intestinal crypts, was measured by the
microcolony assay (Withers & Elkind, 1970). Four
mice were used per experimental point at low doses
of drug, 6 mice at high doses. Animals were killed
4.0 days after treatment, the jejunum was removed
and 5,um-thick transverse sections stained with
haematoxylin and eosin, were prepared. The
number of regenerating crypts per circumference of
transverse section, was scored (12 to 30
circumferences per dose-point per experiment) and
a surviving fraction (SF) of crypts was calculated
relative to saline-injected controls (121 crypts per
circumference, standard error 2, 35 mice). The
proliferative response of crypts varies somewhat
between cytotoxic agents (e.g. Hagemann, 1980), so
that when assaying at one time interval, average
crypt size may also vary. This influences the
probability of transecting a crypt in a section of
fixed thickness and hence influences the apparent
SF of crypts. A correction factor has been applied
to accommodate differences in crypt size: final
SF =raw SF x average crypt diameter in control
intestine/average crypt diameter in treated intestine
(discussed in Potten & Hendry, 1983). Results were
confirmed by at least one repeat experiment, the
data being pooled.
The histopathological consequences of treatment
were measured in groups of 3 mice that were killed
at intervals up to 96h after injection of drug.
Transverse sections ofjejunum were prepared. Only
crypts that were clearly bisected along their
longitudinal axis were scored, to a total of 30 crypt
columns per animal (i.e. 30 half-crypts, measured in
30 different crypts). Cell death was defined in terms
of changes to the cellular nucleus, i.e. hyper-
chromasia associated with nuclear condensation
(pyknosis) or fragmentation (karryorhexis). A single
pyknotic focus, or a group of fragments in close
spatial association, was scored as one necrotic cell.
These cells were scored with respect to the position
of the cell in the crypt, up to position 21 from the
base. For analysis of results, the crypt was divided
into 3 zones: cell positions 1 to 7 from the crypt
base ("lower"), 8 to 14 ("middle") and 15 to 21
("upper"). The number of mitotic or necrotic cells
per zone per crypt column was obtained for each
animal and from these values a mean and standard
error (1 s.d./,/3) was calculated for the 3 animals
in each group. Crypt height was measured in terms
of cell number, for those crypts in which a distinct
outward bend was observable at the upper end of
the column.
Results
Clonogenic assay ofcrypt response
The 6 drugs yielded widely-different curves of crypt
survival versus dose of agent (Figure 1). In the
microcolony assay by drug or radiation, the upper
limit of dose is dictated by the ability of the animal
to survive for 3 days or more. If other, rapid
toxicities intervene (e.g. cardiotoxicity in the case of
ADR), then there is no opportunity to extend the
curve to low levels of crypt survival (i.e. using doses
much greater than LD75/4). In Figure 1, the highest
dose of each drug represents this biologically-
imposed limit. Neither CY nor ACT D ablated
crypts within the measurable dose-range. For the
other 4 drugs, a computer program was used to
calculate the parameters Do (1/final slope of the
curve) and N, the extrapolation number of the
crypt survival curve (Gilbert, 1974). Respectively,
mean Do (mgkg-1) and N, (both+s.e.) were: HN2
1.5+0.1 and 2.1+0.2; BCNU 27.3+2.9 and
19.7+7.2; ADR 12.9+2.3 and 2.1+0.4; 5-FU
578 +9.2 and 2.3+0.3.
Histological assay ofcrypt response
In this experiment, doses of the 6 drugs.were
chosen to be equitoxic to the animal, i.e. the
LDlO/8day doses. These were: 325mgkg-1 of CY,
3.5mgkg- 1 of HN2, 40mgkg-1 of BCNU,
550pgkg-1 of ACT D, 200mgkg-1 of 5-FU, and
13.5mgkg-' of ADR. The time course of incidence
and distribution of necrotic cells varied little
between the drugs. The results for BCNU are
representative (Figure 2). Full development of
necrosis occurred in less than 12h and numbers of
necrotic cells fell progressively after 24h. The mean
height of crypts measured by cell number, reached
a nadir at 24h and recovered to control numbers orCRYPT DEATH AND CELL DEATH IN DRUG-TREATED INTESTINE 27
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Figure 1 Surviving fraction of intestinal crypts versus dose of each of 6 cytotoxic drugs. Error bars +2s.e.
N.B. ACT-D dose should be ugkg-1.
greater by 3-4 days. The distribution of necrotic
cells versus cell position was skewed to the right
and very few occurred above position 21. The
median of the distribution of necrotic cells, for each
interval between 5 and 24h, was calculated for the
6 drugs. Because crypt height changed during this
period, the median was calculated in two ways: (i)
by assigning necrotic cells to an absolute position
above position I in the crypt base, (ii) by assuming
that reduction in crypt height represented loss of
necrotic cells from various positions in the crypt,
and relating the remaining "occupied" positions to
those in controls by multiplying the absolute
position by the factor: crypt height in controls (24
cells)/crypt height after treatment (n cells). Results
are presented in Figures 3 and 4. Taking the mean
of the medians of the distribution of necrotic cells
for all intervals between 5 and 24h, the lowest
value was for ADR (position 5 by method (i), 6 by
method (ii), <BCNU, <HN2, <ACT D, <CY,
<5-FU (position 7 (i), 9 (ii)). Thus the majority of
necrotic cells were found in the lower half of the
crypt. The mean number of necrotic cells per crypt
(5-24h) was least for 5-FU (1.73+0.22) <HN2
<BCNU<ADR<ACT D<CY (2.70+0.53).
The distributions of necrotic cells were analysed
further by calculating the number of necrotic cells
for columns of 7 cells in the lower, middle and
upper thirds of crypts. Positions were measured by
method (i), i.e. values for the upper third were
made only in crypts that still had 21 cells
remaining. Little cell necrosis was induced above
position 14, for any drug (Figures 3 and 4). The 2
agents that failed to kill crypts, CY and ACT D,
had relatively high medians for the overall
distribution of necrotic cells but this was caused by
high incidence of cell necrosis in the middle third of
the crypt, and not by a low incidence in the lower28 J.V. MOORE
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Figure 2 Frequency of necrotic cells versus cell position in jejunal crypts of mice treated by BCNU.
Measurements made between lh and 96h after treatment. Vertical dashed lines denote positions 7 and 14.
Arrow shows median of distribution versus position. Number in parenthesis is mean crypt height in terms of
cell number. Frequency ofnecrotic cells in crypts of untreated animals was <0.04 per crypt column.
third. The highest value of the median of necrotic
cell distribution was for 5-FU, which did ablate
crypts.
Discussion
Using radiation, several estimates have been made
of the number of MFU in jejunal crypts of B6D2F1
(Paterson) mice. This number is determined
indirectly, being the quotient (N/E) of the extra-
polation numbers of crypt survival curves after
single doses of radiation (N) and doses given 4 to
5h after a high first dose (E; e.g. Hendry & Potten,
1974). In such calculations, it is assumed that cells
survive independently of each other and that one
surviving clonogenic cell is sufficient to regenerate
the crypt (Withers & Elkind, 1970). The errors on
such estimates are large, but the average value from
these repeated experiments is -80MFU per crypt
(Potten & Hendry, 1983). This is more than the
number of slowly-proliferating cells in the crypt
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Figure 3 Frequency of necrotic cells in the lower (cell positions 1-7), middle (8-14) and upper (15-21) third
of crypt columns at intervals between 1 and 24h after CY, HN2, or BCNU. Rows of figures at top (7/7, 8/9,
etc.) show, for each drug, the cell position corresponding to the median of the distribution of necrotic cells,
for each interval. The left-hand figure in each pair is the median calculated by method (i), the right-hand
figure by method (ii) (see text).
base, but fewer than the total number of
proliferating cells. However, 80 represents one half
of the number of all proliferating cells so that, if
the functional failure and death of MFU is
expressed through necrosis, gross differences in
clonogenic response might have been expected to be
reflected in the histological response.
Two of the 6 drugs, CY and ACT D, failed to
destroy crypts after a range of non-lethal and lethal
(LDO/36-LD75/4day) doses (Figure 1). This cytotoxic
inefficiency was not reflected by any marked
differences in the histological death of cells in the
crypt for CY and ACT D compared with the other
drugs (Figures 3 and 4). Over the first 24h after
treatment with the LD10/8 doses of the 6 drugs, thc
average number of necrotic cells per crypt section
(2 columns) ranged between 3.5-5.4, equivalent to
5.8-9.0 per "whole crypt" (160 proliferative cells;
B
Hendry et al., 1982). This compares with a
maximum plateau value of 6 per whole crypt,
obtained after doses in the range 0.2 to 10Gy of
various low-LET radiations (Potten, 1977; Hendry
& Potten, 1982; Moore et al., 1982). Hendry &
Potten (1982) have suggested that the low observed
numbers of necrotic cells could (a) represent a small
compartment of clonogenic and/or non-clonogenic
cells with high sensitivity to radiation, relative to
the 80 or so "cells" (units) whose response is
believed to be measured by the microcolony assay,
or (b) represent a proportion of the MFU, sharing
the same sensitivity for sterilisation, but expressing
their damage early, by necrosis.
Using cytotoxic drugs, the calculated values for
numbers of MFU per crypt were very much lower
than for radiation; 2 for HN2, ADR and 5-FU, and
20 for BCNU. The former three drugs had an E of30 J.V. MOORE
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Figure 4 Frequency of necrotic cells in the lower, middle and upper third of crypt columns at intervals
between 1 and 24h after ACT D, 5FU, or ADR. Details as for Figure 3.
1, so that N also represents the number of MFU.
There is an appreciable split-dose effect with
BCNU (Moore, 1979), yielding a final MFU
number of 6 or 7. The curves for ADR and 5-FU
extended to less than 1 log of crypt depletion and
may represent a shoulder region with finite slope,
but those for HN2 and BCNU extend over 3 logs.
Assuming (as for radiation) that the crypt response
to drug does reflect the independent responses of
epithelial cells, then these results lead to the
conclusions that (a) the size of the measurable
MFU compartment is dependent on the agent of
assay, and (b) the more-or-less constant numbers of
necrotic cells induced by LD10/8 doses of drugs or
radiation, differ in their proportion with respect to
the MFU compartment: 6 necrotic cells/80 MFU
for radiation, 8/7 for BCNU and 8/2 for HN2. Why
should the numbers of MFU differ so radically
between agents? Whole crypts are first ablated by
an agent when, on average, fewer than 3 MFU per
crypt survive (Poisson distribution). These are
presumably cells that are most resistant to the
action of that particular agent. It has been argued
from radiation studies, that approximately 80 MFU
in a crypt of 160 proliferating cells share the
survival characteristics of those final few that
actually determine crypt survival (Potten and
Hendry, 1983). In the cases of HN2, ADR and
5-FU, it is possible that only 2 MFU were resistant
to the action of the drugs, while the remaining 80
minus 2 (or 160 minus 2?) were profoundly
sensitive. Against this interpretation are the facts
that (a) such "sensitivity" was not expressed in a
greatly increased number of necrotic cells relative to
radiation (this paper), (b) experiments using graded
low doses of drug plus high test doses of radiation
failed to reveal a sensitive compartment (Moore,
1979; Moore & Broadbent, 1980), (c) the known
cell cycle phase-specificities of the three drugs are
quite different (e.g. Hill & Baserga, 1975), (d) while
5-FU has a very long biological half-life (Myers et
al., 1974) and might therefore kill many cells
recruited from a more resistant state, HN2 has a
half-life of only a few minutes (Nadkarni et al.,
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1956) and can be classed with radiation as an
"acute" treatment. It may be that the response of a
whole crypt cannot be interpreted simply in terms
of the independent responses of cells of a
particular, numerically-fixed population, but that
considerations of cooperation within and between
populations have a bearing on the observed overall
result of a treatment. It could be speculated that
for a microcolony to form, a focus (MFU) of more
than one cell may be required, and that the number
of cells per MFU may vary between cytotoxic
agents. With regard to the number of necrotic cells
vs MFU, Hendry & Potten (1982) considered
whether the former might represent a sub-
compartment of the latter. Plainly, if one adheres to
the view that MFU are individual cells, this is not
so for HN2 (8 necrotic cells, 2MFU), a result which
would then suggest that necrotic cells can arise
from non-MFU. If the MFU compartment in CY-
or ACT D-treated mice is also small, consisting of
a very few cells that are highly resistant to these
agents, then there is only a poor probability of
detecting the response of such cells by histological
means. The cell necrosis that is observed after CY
or ACT D (Figures 3 and 4) would occur in a non-
MFU, possibly amplification, compartment.
Certain other drugs that do not ablate crypts
even with very large single doses, have a high value
for the median of the distribution of numbers of
necrotic cells versus cell position e.g. vincristine-
median position 9 method (i) (Moore et al., 1982)
or hydroxyurea-median position 10 to 13 (Ijiri &
Potten, 1983). The distribution curves for these
drugs are more symmetric than those for radiation
(median 5; Moore et al., 1982) or ADR (median 5,
this paper), not only because more cells are killed
above position 14 but also because fewer cells are
killed at or below position 5, the putative stem cell
zone (Cheng & Bjerknes, 1980). We would now
conclude, from results for CY and ACT D, that
even a relatively high degree of histologically-
defined cell death in this zone does not necessarily
predispose to death of the crypt.
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